Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AA Colony stimulating factors
L03AA02 Filgrastim
D03235 Filgrastim (USP/INN) <JP/US>
USP drug classification [BR:br08302]
Immunological Agents
Immunostimulants
Colony-stimulating Factors
Filgrastim
D03235 Filgrastim (USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
339 Miscellaneous
3399 Others
D03235 Filgrastim (USP/INN); Filgrastim (genetical recombination) (JP18); Filgrastim (genetical recombination) [Filgrastim biosimilar 1] (JAN); Filgrastim (genetical recombination) [Filgrastim biosimilar 2] (JAN); Filgrastim (genetical recombination) [Filgrastim biosimilar 3] (JAN)
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
D03235 Filgrastim
Drug classes [BR:br08332]
Immunological agent
DG01753 Colony stimulating factor
D03235 Filgrastim
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
CSF3R (GCSFR, CD114)
D03235 Filgrastim (USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D03235 Filgrastim (genetical recombination)
D03235 Filgrastim (genetical recombination) injection
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03235
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03235
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03235